Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $158.0K in total
- 5
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +9 vs. previous quarter
- 20
- 13F valueReported value at the end of Q2 2026
- $220.0K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BMRA, Q2 2026
No superinvestor reported holding BMRA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Biomerica Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 (view filing)5:27 PM ET | Aug 20 | 7 daysLate | Gary M. HuffDirector | PPurchase | +31.3K | $1.60 | +$50.0K | +156.3%51.3K after | |
| Aug 27, 2026 (view filing)5:26 PM ET | Aug 26 | 1 day | Moatazedi DavidDirector | PPurchase | +10.0K | $1.60 | +$16.0K | +32.7%40.6K after | |
| Aug 27, 2026 (view filing)5:26 PM ET | Aug 26 | 1 day | Chin EricDirector | PPurchase | +6.25K | $1.60 | +$10.0K | +19.2%38.8K after | |
| Aug 27, 2026 (view filing)5:24 PM ET | Aug 26 | 1 day | Barbieri AllenExecutive Vice Chairman | PPurchase | +20.0K | $1.60 | +$32.0K | +37.4%73.5K after | |
| Aug 27, 2026 (view filing)5:23 PM ET | Aug 26 | 1 day | Irani Zackary S.Chief Executive Officer | PPurchase | +31.3K | $1.60 | +$50.0K | +14.8%242.6K after | |
| May 26, 2023 (view filing) | May 24-25 | 2 days | Irani Zackary S.Chief Executive Officer | PPurchase | +700 | $1.59 | +$1.11K | +0.1%1.02M after | 2 lots |
| May 12, 2023 (view filing) | May 12 | Same day | Irani Zackary S.Chief Executive Officer | PPurchase | +1.70K | $1.17 | +$1.99K | +0.2%1.02M after | |
| May 12, 2023 (view filing) | May 10 | 2 days | Irani Zackary S.Chief Executive Officer | PPurchase | +500 | $1.27 | +$635 | 0.0%1.02M after | |
| May 10, 2023 (view filing) | May 9 | 1 day | Irani Zackary S.Chief Executive Officer | PPurchase | +300 | $1.39 | +$417 | 0.0%1.02M after | |
| May 5, 2023 (view filing) | May 4 | 1 day | Irani Zackary S.Chief Executive Officer | PPurchase | +1.00K | $1.36 | +$1.36K | +0.1%1.02M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Biomerica Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 26,374 | $46.0K | 0.00% | +26,374 | New |
| Geode Capital Management, LLC | 24,347 | $42.9K | 0.00% | −31,695−56.6% | Reduced |
| BlackRock, Inc. | 18,636 | $32.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 14,514 | $25.5K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,640 | $22.2K | 0.00% | +12,640 | New |
| LPL Financial LLC | 10,849 | $19.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,951 | $12.2K | 0.00% | +6,432+1,239.3% | Added |
| Vanguard Fiduciary Trust Co | 6,613 | $11.6K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 3,603 | $6.34K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 238 | $419 | 0.00% | +238 | New |